different pattern of gene mutations in iranian patients with severe congenital neutropenia (including 2 new mutations).
Authors
abstract
severe congenital neutropenia (scn) is a rare primary immunodeficiency disease. different genes are found to be associated with scn, including ela2, hax1, was, gfi1, g-csfr and g6pc3. the aim of this study was to find different gene mutations responsible for scn in iranian patients. twenty-seven patients with scn referred to immunology, asthma and allergy research institute during a five year priod 5 years (may 2007 and may 2012), were included in this study. neutropenia related exons and flanking regions of ela2, hax1, was, gfi1, g-csfr and g6pc3 were amplified by pcr and the sequences were analyzed. the results showed different mutations including 4 elane mutations, 11 hax1 mutations and 2 g6pc3 mutations. none of the patients had gfi1 mutation and also one mutation was found in g-csfr in a patient with elane mutation. ten patients had unknown genetic diagnosis which was compatible with other studies. according to these results, most of the patients showed hax1 mutations and this finding which significantly differed from other reports, might be related to differences in iranian ethnicity and also in high rate of consanguineous marriages in iran.
similar resources
Different pattern of gene mutations in Iranian patients with severe congenital neutropenia (including 2 new mutations).
Severe congenital neutropenia (SCN) is a rare primary immunodeficiency disease. Different genes are found to be associated with SCN, including ELA2, HAX1, WAS, GFI1, G-CSFR and G6PC3. The aim of this study was to find different gene mutations responsible for SCN in Iranian patients. Twenty-seven patients with SCN referred to Immunology, Asthma and Allergy Research Institute during a five year p...
full textDigenic mutations in severe congenital neutropenia.
Severe congenital neutropenia a clinically and genetically heterogeneous disorder. Mutations in different genes have been described as causative for severe neutropenia, e.g. ELANE, HAX1 and G6PC3. Although congenital neutropenia is considered to be a group of monogenic disorders, the phenotypic heterogeneity even within the yet defined genetic subtypes points to additional genetic and/or epigen...
full textNovel HAX1 gene mutations associated to neurodevelopment abnormalities in two Italian patients with severe congenital neutropenia.
We read with interest the recent perspective article by Klein. 1 Genetic analysis in individuals with severe congenital neutropenia (SCN) indicates that 60% of cases were attributable to heterozygous mutation in ELA2 gene encoding neutrophil elastase. 2 Homozygous mutation in HAX1 gene has been identified in patients with autosomal recessive form of SCN (Kostmann syndrome). 3 Patients with ELA2...
full textHeme Oxygenase-2 Gene Mutations and Blood Bilirubin Level in Iranian Patients with Premature Atherosclerosis
Heme oxygenase-2 (HO-2) is a critical antioxidative stress enzyme found in endothelial cells and adventitialnerves. This enzyme in conjunction with other HOs (1 and 3) metabolize heme molecule into ferrous iron,carbon monoxide (CO), and biliverdin which is further converted to bilirubin. Both biliverdin and bilirubin arepotent antioxidants, reducing the risk of atherosclerosis...
full textThe Frequency of Eight Common Point Mutations in CYP21 Gene in Iranian Patients with Congenital Adrenal Hyperplasia
Background: Congenital Adrenal Hyperplasia (CAH, the inherited inability to synthesize cortisol) is one of the most common (1 in 10000 to 1 in 15000) autosomal recessive disorders. More than 95% of cases of CAH are caused by 21-hydroxylase deficiency (21-OHD). Females with severe, classic 21-OHD are exposed to excess androgens prenatally and are born with virilized external genitalia. Most pati...
full textMolecular and Clinical Characterization of 7 Iranian Patients with Severe Congenital Factor V Deficiency: Identification of 4 Novel Mutations
Background and Aims: Congenital factor V (FV) deficiency is a rare bleeding disorder with 1 in 1000000 persons in the general population. Individuals with FV activity <1% and very low FV antigen levels are characterized as severe FV deficient patients. Little data is available about the molecular basis of this bleeding disorder in Iran. Materials and Methods: We analyzed 7 unrelated Iranian FV...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of allergy, asthma and immunologyجلد ۱۲، شماره ۱، صفحات ۸۶-۹۲
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023